World Asset Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
RCM
World Asset Management's NVAX Position: Q3 2021 in Review
World Asset Management reduced its Novavax (NVAX) stake by 9.7% in Q3 2021, selling an estimated $24.9K and leaving 1,055 shares worth $219K. The position accounts for 0.02% of the portfolio, ranked #771.
World Asset Management first reported a position in NVAX in Q2 2013 and has held it in 10 quarters since. The position peaked at $249K in Q1 2021. 442 funds tracked by Wall St. Rank hold NVAX as of Q3 2021.
- World Asset Management held 1,055 shares of Novavax worth $219K as of Q3 2021.
- World Asset Management sold 113 Novavax shares in Q3 2021, an estimated $24.9K.
- Novavax made up 0.02% of World Asset Management's portfolio in Q3 2021, its #771 holding.
- World Asset Management first reported a position in Novavax in Q2 2013 and has held it in 10 quarters since.
- World Asset Management's Novavax position peaked at $249K in Q1 2021.
- 442 funds tracked by Wall St. Rank held Novavax as of Q3 2021.
Based on World Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.